4/A//SEC Filing
Eichenfield Lawrence 4/A
Accession 0001209191-21-041443
CIK 0001660334other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:31 PM ET
Size
6.0 KB
Accession
0001209191-21-041443
Insider Transaction Report
Form 4/AAmended
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-10+8,109→ 8,109 totalExercise: $10.56Exp: 2031-06-09→ Common Stock (8,109 underlying)
Footnotes (2)
- [F1]The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted.
- [F2]The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001814892
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:31 PM ET
- Size
- 6.0 KB